{"disease":{"id":"malignant-hematologic-neoplasm","name":"malignant hematologic neoplasm"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03222258","title":"Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":444,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05058339","title":"Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":223,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07172191","title":"Fecal Microbiota Transplantation Among Adult Patients With Hematological Malignancies","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Del-Pest Central Hospital - National Institute of Hematology and Infectious Diseases","has_results":false},{"nct_id":"NCT04024618","title":"Feasibility Study Comparing Enteral vs Parenteral Nutritional Outcomes in Autologous Stem Cell Transplant Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT06480630","title":"Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":39,"lead_sponsor_name":"Anhui Provincial Hospital","has_results":false},{"nct_id":"NCT04760184","title":"Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT03878524","title":"Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"OHSU Knight Cancer Institute","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}